Table 2.

Number of participants by sex for each medication category along with the counts of specific medications. Some participants were taking multiple medications so the count of individual medications may be larger than the number of participants within that group

	No meds	Only first-line	Only non-first-line	Combination
Sex	N = 157	N = 111	N = 21	N = 22
Female, (N,%)	65 (41.4)	50 (45.0)	N = 16 (80.0)	N = 14 (63.6)
		ACE-inhibitor (17), Angiotensin Receptor Blocker (10), Dihydropyridine CCB (21), Thiazide diuretic (18)	Alpha/beta blocker (2), Beta Blocker (10), Central agonist (2), Loop diuretic (1), Potassium-sparing diuretic (3), Vasodilator (1)	ACE-inhibitor (3), Alpha/beta blocker (1), Angiotensin Receptor Blocker (5), Beta Blocker (8), Dihydropyridine CCB (3), Loop diuretic (1), Potassium-sparing diuretic (5), Thiazide diuretic (5), Vasodilator (1)
Male, (N,%)	92 (58.5)	61 (55.0)	N = 5 (24.0)	N = 5 (22.7)
		ACE-inhibitor (37), Angiotensin Receptor Blocker (11), Dihydropyridine CCB (15), Non-dihydropyridine CCB (1), Thiazide diuretic (20)	Beta Blocker (5)	ACE-inhibitor (4), Alpha/beta blocker (1), Angiotensin Receptor Blocker (3), Beta Blocker (4), Central agonist (1), Dihydropyridine CCB (2), Loop diuretic (2), Potassium-sparing diuretic (1), Thiazide diuretic (3)